Biomedix Incubator Ltd
Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. The firm seeks to invest in life science sector including medical equipment, green technology, software, and alternative energy. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York.
Biomedix Incubator Ltd (BMDX) - Net Assets
Latest net assets as of June 2017: ILA5.58 Million ILA
Based on the latest financial reports, Biomedix Incubator Ltd (BMDX) has net assets worth ILA5.58 Million ILA as of June 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA5.77 Million) and total liabilities (ILA192.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA5.58 Million |
| % of Total Assets | 96.67% |
| Annual Growth Rate | -32.71% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 11.46 |
Biomedix Incubator Ltd - Net Assets Trend (2013–2016)
This chart illustrates how Biomedix Incubator Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Biomedix Incubator Ltd (2013–2016)
The table below shows the annual net assets of Biomedix Incubator Ltd from 2013 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-12-31 | ILA6.70 Million | -16.35% |
| 2015-12-31 | ILA8.01 Million | -35.25% |
| 2014-12-31 | ILA12.37 Million | -43.77% |
| 2013-12-31 | ILA22.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biomedix Incubator Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1529800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2016)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA1.39 Million | 20.75% |
| Other Components | ILA187.83 Million | 2803.40% |
| Total Equity | ILA6.70 Million | 100.00% |
Biomedix Incubator Ltd Competitors by Market Cap
The table below lists competitors of Biomedix Incubator Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DUNELM GROUP
BE:DFQ
|
$120.01K |
|
ALPS ELECTRIC CO
MU:ALE
|
$120.09K |
|
BMEB4F
SA:BMEB4F
|
$120.10K |
|
Piscines Jean Desjoyaux
BE:DJX
|
$120.12K |
|
DOCCHECK N (AJ91.SG)
STU:AJ91
|
$119.91K |
|
Vinacafe Bien Hoa JSC
VN:VCF
|
$119.89K |
|
Madison Technologies Inc
PINK:MDEX
|
$119.88K |
|
PortfolioMan ØU Inv Balan kl n
CO:PMIOUIB
|
$119.84K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biomedix Incubator Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2015 to 2016, total equity changed from 8,010,000 to 6,700,000, a change of -1,310,000 (-16.4%).
- Net loss of 1,310,000 reduced equity.
Equity Change Factors (2015 to 2016)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-1.31 Million | -19.55% |
| Total Change | ILA- | -16.35% |
Book Value vs Market Value Analysis
This analysis compares Biomedix Incubator Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Biomedix Incubator Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -19.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (-19.55%) is above the historical average (-54.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -65.28% | -34190.48% | 0.00x | 1.03x | ILA-16.56 Million |
| 2014 | -77.83% | 0.00% | 0.00x | 1.05x | ILA-10.87 Million |
| 2015 | -54.43% | 0.00% | 0.00x | 1.06x | ILA-5.16 Million |
| 2016 | -19.55% | 0.00% | 0.00x | 1.03x | ILA-1.98 Million |
Industry Comparison
This section compares Biomedix Incubator Ltd's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $37,230,000
- Average return on equity (ROE) among peers: -21.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biomedix Incubator Ltd (BMDX) | ILA5.58 Million | -65.28% | 0.03x | $119.97K |
| Black Sea Property PLC Ordinary Shares (BSP) | $1.91 Million | -202.26% | 1.13x | $54.45K |
| Ai Conversation Systems Ltd (FVT) | $22.19 Million | 66.99% | 2.97x | $7.32K |
| Gamatronic Electronic Industries Ltd (GAMT) | $108.08 Million | 0.13% | 0.24x | $38.22K |
| Panaxia Labs Israel Ltd (HROD) | $12.92 Million | -39.72% | 1.29x | $107.94K |
| The Israel Land Development Company Ltd (ILDA) | $21.85 Million | -30.46% | 0.50x | $30.38K |
| Insuline Medical Ltd (INSL) | $-2.26 Million | 0.00% | 0.00x | $6.99K |
| Itay Financial A.A Investments Ltd (ITYF) | $20.94 Million | 32.06% | 24.49x | $10.35K |
| Micronet Ltd (MCRNL) | $62.64 Million | -1.68% | 0.65x | $13.97K |
| Netz Hotels Ltd (NZHT) | $86.81 Million | -22.84% | 0.00x | $1.49K |